0001104659-24-001955.txt : 20240105
0001104659-24-001955.hdr.sgml : 20240105
20240105210420
ACCESSION NUMBER: 0001104659-24-001955
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240103
FILED AS OF DATE: 20240105
DATE AS OF CHANGE: 20240105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Urbach Tanya Durkee
CENTRAL INDEX KEY: 0001897672
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-49908
FILM NUMBER: 24518110
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET
STREET 2: SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytoDyn Inc.
CENTRAL INDEX KEY: 0001175680
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 753056237
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
BUSINESS PHONE: 360-980-8524
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
FORMER COMPANY:
FORMER CONFORMED NAME: CYTODYN INC
DATE OF NAME CHANGE: 20031114
FORMER COMPANY:
FORMER CONFORMED NAME: REXRAY CORP
DATE OF NAME CHANGE: 20020617
4
1
tm242134-6_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-03
0
0001175680
CytoDyn Inc.
CYDY
0001897672
Urbach Tanya Durkee
1111 MAIN STREET, SUITE 660
VANCOUVER
WA
98660
1
0
0
0
0
Common Stock
162113
D
Non-qualified stock option (right to buy)
0.21
2024-01-03
4
A
0
800000
0
A
2034-01-03
Common Stock
800000
800000
D
466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024.
/s/ Antonio Migliarese, Attorney-in-Fact for Tanya Durkee Urbach
2024-01-05